Company Data
MiNK Therapeutics Inc.
Ticker
INKT
Current Price
$11.96 -3.39%
Market Cap
$59.6M
Price Target
Refer to Report
Volume
37.5K
52wk Range
$6.8 - $76
Overview
MiNK Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing allogeneic invariant natural killer T cell therapies to treat cancer and other life-threatening illnesses.